XIST Inhibition Attenuates Calcium Oxalate Nephrocalcinosis-Induced Renal Inflammation and Oxidative Injury via the miR-223/NLRP3 Pathway

<div>Schematic diagram XIST inhibition decreases CaOx crystal-induced inflammatory and oxidative kidney injury by interacting with miR-223-3p and the NLRP3/Caspase-1/IL-1<i>β</i> pathway.</div>

Oxidative Medicine and Cellular Longevity

fig7

Figure 7

Figure 7: XIST Inhibition Attenuates Calcium Oxalate Nephrocalcinosis-Induced Renal Inflammation and Oxidative Injury via the miR-223/NLRP3 Pathway 